Carnegie Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARNEGIE, and what generic and branded alternatives to CARNEGIE drugs are available?
CARNEGIE has nine approved drugs.
Drugs and US Patents for Carnegie
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carnegie | PRIMIDONE | primidone | TABLET;ORAL | 218366-001 | Jan 23, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Carnegie | ETRAVIRINE | etravirine | TABLET;ORAL | 215402-001 | Apr 13, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Carnegie | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 202077-001 | Feb 11, 2013 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Carnegie | RASAGILINE MESYLATE | rasagiline mesylate | TABLET;ORAL | 201942-001 | Nov 18, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |